Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals

WHO validates Convidecia vaccine for Covid-19

The vaccine was found to have 64% efficacy against symptomatic disease and 92% against severe Covid-19

Freudenberg Medical launches HelixFlex TPE tubing at Pharmapack 2022

TPE tubing from Freudenberg also offers many different sterilization options including autoclave, gamma irradiation, x-ray, and e-beam

BenevolentAI achieves third milestone in its AI-enabled drug discovery collaboration with AstraZeneca

A total of three targets have been selected for portfolio entry in the collaboration to date, with the potential to generate further future development milestones and sales-based royalty revenues for BenevolentAI

Eight Roads announce US $ 250 million healthcare fund for India

This new fund is amongst the largest for the sector in India

BDR Pharma receives Rs. 685 crore of PE investment

Multiples is the first private equity (PE) investor in the company

Moderna announces advancements in mRNA platform science for application across multiple diseases

Moderna continues to expand its mRNA platform for a range of additional clinical applications and routes of administration including a modality for lung delivery

Adroit BioMed launches Fortisil range of skincare products

Takeda launches Adynovate for Hemophilia patients in India

Adynovate in combination with Mypkfit offers personalized treatment and enables HCPs and patients to monitor factor levels from home and help achieve optimum QOL outcomes

Zydus launches Bemdac to treat LDL-Cholesterol

It is a new class of drug that treats uncontrolled LDLCholesterol, despite the use of a maximum tolerated dose of statins